Allarity Therapeutics completes a $6 million stock purchase agreement with Thommy Stone Capital.
Allarity Therapeutics completes a $6 million stock purchase agreement with Thommy Stone Capital.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in